FTC
-
UnitedHealth’s $4.3B DaVita Medical acquisition wins conditional FTC approval
The effort by the nation’s largest insurer to become the nation’s largest employer of clinicians received FTC approval with an agreement to divest some of the company’s holdings in the Las Vegas area to address antitrust issues.
-
Startups, Health Tech, Medical Education
Playing doctor: The evolution of videogames in healthcare
As videogames have become mainstream and emerged from the dimly-lit arcade rooms of years past, gaming technology has found increasing application in medical training, pain management, rehab, and digital therapeutics.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Florida-based Simple Health Plans shut down for selling “sham insurance”
According to the FTC, Simple Health Plans and its subsidiaries collected more than $100 million through deceptive marketing and sales practices that left many people stuck with thousands in unpaid medical costs.
-
Goal setting digital health business Pact reaches $1.5M settlement with FTC
Consumers who used the Pact app made “pacts” to exercise a certain number of times per week or meet dietary goals, and agreed to be automatically charged an amount, ranging from $5 to $50 per missed activity if they did not complete their pacts.
-
Health IT, Devices & Diagnostics, Diagnostics
FTC’s settlement with blood pressure app developer echoes frustration with misleading claims
The agreement bars Aura Labs and founder Ryan Archdeacon from claiming that the Instant Blood Pressure app is as accurate as a traditional blood pressure cuff.
-
Pfizer-Allergan ruling sets a dangerous precedent
Fundamentally, my biggest concern with the new rules regards the importance of predictability in business. Strategic planning, essential to running sustainable enterprises, requires the predictability of transparent and forward-looking laws, along with proper due process and accountability.
-
Choose your own regulatory adventure: Interactive rule guide targets digital health developers
The guide, in collaboration with U.S. Food and Drug Administration, Office of National Coordinator and Office of Civil Rights, is a departure from typically dry, convoluted government documents.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Why Shkreli won’t talk drug prices at Congressional hearing: Turing investigated by FTC for antitrust violations
Martin Shkreli won’t talk drug prices at his forthcoming Congressional hearing, because Turing Pharmaceuticals is under an FTC antitrust probe.